US Patent Issued to Beijing Hebabiz Biotechnology, Beijing Hebabiz Management on March 31 for "Composition containing nicotinamide mononucleotide and mogroside, and application thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,107, issued on March 31, was assigned to Beijing Hebabiz Biotechnology Co. Inc. (Beijing) and Beijing Hebabiz Management Co. Ltd. (Beijing).

"Composition containing nicotinamide mononucleotide and mogroside, and application thereof" was invented by James Zhou (Westport, Conn.), Bai-Bo Xie (Beijing) and Xinyu Zang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the medical and technical field and provides a medicine or health food composition of nicotinamide mononucleotide and mogroside. In addition, the present invention also provides the preparation method, formulation and application of the composition." ...